Artivion Inc. (AORT), a cardiac and vascular surgery company specializing in aortic disease, is experiencing a banner year, with shares surging nearly 64% year-to-date to trade around $25.
The company manufactures, processes, and distributes medical devices and implantable human tissues that are used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and related surgical products, and implantable cardiac and vascular human tissues.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com